Clinical Scorecard: Investigation of the Relationship Between Ventricular Arrhythmia and Heart Rate Variability in Individuals with Coronary Heart Disease
At a Glance
Category
Detail
Condition
Coronary Heart Disease with Ventricular Arrhythmia
Key Mechanisms
Heart Rate Variability as a marker for Ventricular Arrhythmia risk
Target Population
Patients with Coronary Heart Disease
Care Setting
Clinical monitoring and assessment
Key Highlights
Ventricular arrhythmia is a common complication in coronary heart disease.
Heart rate variability indices were significantly lower in patients with ventricular arrhythmia.
SDANN, rMSSD, and PNN50 are associated with the occurrence of ventricular arrhythmia.
Dynamic electrocardiogram monitoring is used to assess heart rate variability.
Guideline-Based Recommendations
Diagnosis
Ventricular arrhythmia diagnosed based on 24-hour ambulatory ECG results.
Management
Patients should discontinue medications affecting heart rate and blood pressure prior to HRV assessment.
Monitoring & Follow-up
Continuous monitoring of heart rate variability is recommended for risk stratification.
Risks
Poor drug compliance and socioeconomic status may increase mortality in patients with ventricular arrhythmia.
Patient & Prescribing Data
320 patients with coronary heart disease, divided into VA and non-VA groups.
Patients with ventricular arrhythmia may require closer monitoring and tailored management strategies.
Clinical Best Practices
Utilize dynamic ECG for comprehensive assessment of heart function.
Monitor heart rate variability as a potential risk indicator for ventricular arrhythmia.
Heart rate monitoring and atrial fibrillation detection had the strongest supporting evidence, but investigators found limited evidence for broader outpatient self-monitoring applications.
